Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF screener
364970
KR7364970004
Passive ETFEquity

364970 ETF · Mirae Asset TIGER BIO TOP10 ETF

The 364970 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: KRX Bio TOP 10 Index. The 364970 ETF provides physical exposure, so by buying it you actually own parts of all the 10 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update 5/8/2026, 12:00 AM UTC
LIVE
CLOSED
This fund is part ofAPAC Blended Cap1M perf.+16.55%
Last price
â‚©7,730
1M perf.
-0.65%
1M flows
+€18M
AuM
€171M
TER
0.42%
Rating
Not rated
ESG Consensus®
esg grade icon
364970
â‚©7,730

Performance & flows

Segment for quartile rank
February 9, 2026 → May 7, 2026
0-10-50510%MARAPRMAYMARAPRMAY
Create a free account to view the flows graph
364970
â‚©7,875
-11.62%
APAC Blended Cap
+12.48%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-0.65%
icon
-11.62%
icon
+9.15%
icon
+31.53%
icon
-19.73%
icon
-3.31%
+0.04%
-11.82%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) Â· 
Main characteristics
ISIN
KR7364970004
AuM
€171M
icon
TER
0.42%
icon
Replication rating
Not rated
ESG Consensus®
esg grade icon
icon
More details
NAV
5/7/2026
â‚©7,875
1D NAV change
-0.06%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
10
Inception date
10/7/2020
Jurisdiction
South Korea
Distribution
South Korea
Legal structure
Open-end Fund
Base currency
KRW
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
Mirae Asset TIGER BIO TOP10 ETF is an exhcange-traded fund extablished in South Korea. The fund aims to provide return that closely replicates the performance of the KRX Bio TOP 10 Index.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs in your region

227540
1M perf.
-1.26%
TER
0.4%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
-11.62%
icon
+9.15%
icon
+31.53%
icon
-19.73%
icon
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
Republic of Korea
99.13%
Unavailable
0.87%
Sectors
Health Care
92.78%
Consumer Discretionary
4.35%
Unavailable
2.87%
Diversification
Total weight of top 10 holdings out of 10
Top 10 holdings
Data as of March 31, 2026
CELLTRION
SAMSUNG BIOLOGICS CO LTD
ALTEOGEN INC
ABL BIO
PEPTRON
Create a free account to view top holdings
HLB
YUHAN
LEGOCHEM BIOSCIENCES
KR70126Z0002
SK BIOPHARMACEUTICALS CO LTD
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG

ESG Consensus® by Conser

Data as of February 27, 2026
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 364970 ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


364970’s has a Final Sustainability Grade of either C+, C, C-, or D.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
60.94% of holdings have positive scoring
39.94% of holdings have negative scoring
10.24%
46.28%
35.05%
Consensus levels
Strong
Medium
Weak
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

Mirae Asset Global Investments
Mirae Asset Global Investments ID Card
Number of funds
100
Total AuM
€36.09B
Expense ratio range
0.05% - 1%
Average expense ratio
0.3878%
Top 5 funds by Mirae Asset Global Investments
AuM
396500
Mirae Asset TIGER Fn Semiconductor TOP10 ETF€7.11B
102110
Mirae Asset TIGER 200 ETF€5.9B
133690
Mirae Asset TIGER NASDAQ 100 ETF€5.6B
381170
Mirae Asset TIGER US Tech TOP10 INDXX ETF€2.44B
292150
MIRAE ASSET TIGER TOP 10 ETF€1.44B

Frequently asked questions about 364970

What does Mirae Asset TIGER BIO TOP10 ETF, 364970, invest in?

364970 is a Passive ETF. This ETF provides exposure to South Korean Equities.

Which benchmark or index does 364970 replicate?

364970 tracks the KRX Bio TOP 10 Index - KRW, through a optimized sampling replication method.

What is the Total Expense ratio (TER) of 364970?

364970 carries a total expense ratio (TER) of 0.42%, indicating the annual cost for holding the fund.

When was 364970 launched?

364970 was introduced to the market on October 7, 2020. It trades on South Korea

Who is the ETF issuer of 364970?

Mirae Asset TIGER BIO TOP10 ETF, 364970, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.

What is the current assets under management (AUM) of 364970?

364970 oversees €171M in assets as of May 7, 2026.

How has 364970 performed lately?

Based on data from May 7, 2026, 364970 returned -0.65% over the past month, -11.62% over the last three months and -11.82% year-to-date.

What are the latest inflows or outflows for 364970?

As of May 7, 2026, 364970 recorded net flows of +€18M over the last month and +€24M year-to-date.

Does 364970 distribute dividends?

364970 follows a distributing dividend policy, meaning it pays out income to investors. As of May 7, 2026, its 12-month trailing yield was 0.57%.

What are the main country or region exposures of 364970?

As of March 31, 2026, 364970 has significant geographic allocations in Republic of Korea.

In which sector or theme does 364970 invest in?

As of March 31, 2026, 364970 focuses largely on Health Care and Consumer Discretionary.

How many securities does 364970 hold and how diversified is it?

As of March 31, 2026, 364970 holds 10 positions in its portfolio, with 99.13% of assets concentrated in its top 15 holdings.

What are the main positions in 364970?

As of March 31, 2026, 364970 top three holdings include CELLTRION, SAMSUNG BIOLOGICS CO LTD and ALTEOGEN INC.

What is the base currency of 364970?

The base currency of 364970 is KRW.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight